Turnstone Biologics Corp (NASDAQ:TSBX) does about 216.02K shares in volume on a normal day but saw 1251638 shares change hands in the recent trading day. The company now has a market cap of 17.62M USD. Its current market price is $0.76, marking a decrease of -8.24% compared to the previous close of $0.83. The 52 week high reached by this stock is $12.16 whilst the lowest price level in 52 weeks is $0.80.
Turnstone Biologics Corp (TSBX) has a 20-day trading average at $2.2226 and the current price is -93.74% off the 52-week high compared with -4.88% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.4536 and its 200-day simple moving average is $2.7095. If we look at the stock’s price movements over the week, volatility stands at 20.64%, which decreases to 11.20% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 15.15 to suggest the stock is oversold.
The consensus objective for the share price is $7.88, suggesting that the stock has a potential upside of 90.36% over the period.
1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
BofA Securities initiated its price target at $18.
Turnstone Biologics Corp (TSBX) stock is down -67.03% over the week and -67.86% over the past month. Its price is -70.07% year-to-date and -92.12% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.81 and -3.44 for whole year.
To reach the target analysts have set, the stock logically needs to grow 90.36 percent from here.
The company has a return on investment of -124.74% and return on equity of -134.46%. The beta has a value of 2.83. Price to book ratio is 0.29.
